CA Patent

CA2921381A1 — Compositions and methods for treating chronic urticaria

Assigned to Knopp Biosciences LLC · Expires 2015-02-19 · 11y expired

What this patent protects

Disclosed herein are methods of treating conditions, which may be associated with elevated levels of mast cells, basophils, eosinophils, or a combination thereof, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.

USPTO Abstract

Disclosed herein are methods of treating conditions, which may be associated with elevated levels of mast cells, basophils, eosinophils, or a combination thereof, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.

Drugs covered by this patent

pramipexole-dihydrochloride (PRAMIPEXOLE DIHYDROCHLORIDE)

Patent Metadata

Patent number: CA2921381A1
Jurisdiction: CA
Classification: —
Expires: 2015-02-19
Drug substance claim: No
Drug product claim: No
Assignee: Knopp Biosciences LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.